Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy.
Colon Adenoma, Colorectal Cancer
About this trial
This is an interventional screening trial for Colon Adenoma focused on measuring Computer-aided colonoscopy, Artificial intelligence, Colorectal cancer screening
Eligibility Criteria
Inclusion Criteria:
- Subjects who have given signed informed consent form
- Informed consensus has been obtained that endoscopic resection should be performed if a lesion is found
- Subjects who are scheduled for screening or diagnostic colonoscopy for colorectal cancer (CRC) or surveillance colonoscopy for post-polypectomy follow-up
Exclusion Criteria:
Subjects with any of the following prior history or current conditions:
- Contraindications to colonoscopy
- Inflammatory bowel disease (IBD)
- Colorectal cancer (CRC)
- Familial adenomatous polyposis (FAP)
- Colonic stenosis
- Severe organ failure (cirrhosis of Child C, heart failure of ACC / AHA stage D)
- Active gastrointestinal (GI) Bleeding
- Pregnancy
- Prior colorectal surgery, including colonic or rectal resection (except for appendectomy, surgery on the anus, and polypectomy)
- Undergo colonoscopy within 3 years
Subjects with any of the following conditions per the investigator's judgement:
- High suspicion of IBD, CRC, and FAP.
- High risk of bleeding after endoscopic treatment, and difficult management of anticoagulation or antiplatelet medication.
Sites / Locations
- National Taiwan University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Computer-aided colonoscopy
Standard colonoscopy
The subject will receive the standard colonoscopy procedure simultaneously with a computer-aided detection (CADe) analysis software designed to automatically detect and highlight potential polyps on colonoscopy images in a real-time manner during colonoscopy procedures.
The subject will receive the standard colonoscopy procedure.